Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1377/hlthaff.2021.00028 http://scihub22266oqcxt.onion/10.1377/hlthaff.2021.00028 34097524!ä!34097524 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Health+Aff+(Millwood) 2021 ; 40 (6): 904-909 Nephropedia Template TP {{tp|p=34097524|t=2021. Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic |pdf=|usr=}}{{34097524}} gab.com Text Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic JO: Health Aff (Millwood) http://www.kidney.de/pget.php?&tw=1&pmid=34097524 #FOAvip COVID-19 interrupted delivery of mental health care in the US. During the initial course of the COVID-19 pandemic new starts of antidepressants declined by 7.5 percent, anxiolytics by 5.6 percent, and antipsychotics by 2.6 percent compared with expected levels. Our findings suggest that there is large unmet need for mental health treatment in the US due to COVID-19. Twit Text FOAVip Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic ????Health Aff (Millwood) http://www.kidney.de/pget.php?&tw=1&pmid=34097524 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34097524 #FOAvip English Wikipedia <ref>{{Cite pmid|34097524}}</ref> Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic #MMPMID34097524 Nason I; Stein DT; Frank RG; Stein MB Health Aff (Millwood) 2021[Jun]; 40 (6): 904-909 PMID34097524show ga COVID-19 interrupted delivery of mental health care in the US. During the initial course of the COVID-19 pandemic new starts of antidepressants declined by 7.5 percent, anxiolytics by 5.6 percent, and antipsychotics by 2.6 percent compared with expected levels. Our findings suggest that there is large unmet need for mental health treatment in the US due to COVID-19. |*Antipsychotic Agents/therapeutic use[MESH] |*COVID-19[MESH] |*Mental Disorders/drug therapy/epidemiology[MESH] |Humans[MESH] |Pandemics[MESH] |Psychotropic Drugs/therapeutic use[MESH]Decline In New Starts Of Psychotropic Medications During The COVID-19 (epmc).pdf DeepDyve Pubget Overpricing